Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,238 Jan 1 – Oct 27, 2026
- Disclosed funding
- $257.2B 1858 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 Adjuvia TherapeuticsCompany profile Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. | $8M | Seed | Biotech | United States | Investors | |
 ArchCompany profile Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. | $52M | Series B | Fintech | United States | Investors | |
 ChipAgentsCompany profile ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. | $60M | Series A+Series A | Hardware | United States | Investors | |
| PB Physician-led behavioral health services and technology company | $14.2M | Growth | Healthtech | United States | Investors | |
| C CopySightCompany profile AI IP governance platform for copyright risk management in AI-generated content AI IP governance platform for copyright risk management in AI-generated content | $3M | Seed | Enterprise software | United States | Investors | |
| TB Developing nerve-targeted imaging technologies for surgery. | Undisclosed | Series A | Biotech | United States | Investors | |
 Develops enterprise AI agents for revenue-generating customer interactions. | $30M | Series A | Enterprise software | United States | Investors | |
| OS Secure AI control plane for the enterprise. | $113M | Series B | Cybersecurity | United States | Investors | |
| D A software-first registered agent that automates state filings. | $10M | Series A | Enterprise software | United States | Investors | |
| T ThreatLockerCompany profile Zero Trust cybersecurity platform for endpoints, networks, and cloud systems Zero Trust cybersecurity platform for endpoints, networks, and cloud systems | $190M | Series FSeries C+ | Cybersecurity | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
133rounds3led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
100rounds20led - 3General Catalyst
Hyperbolic, Re:Build, Provision Labs
73rounds8led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Sequoia Capital
Hex, Warhound, Whop
58rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.